Tilt Investment Management Holdings’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$344K Sell
5,950
-1,627
-21% -$86.8K 0.37% 74
2023
Q3
$400K Hold
7,577
0.29% 100
2023
Q2
$410K Hold
7,577
0.27% 98
2023
Q1
$366K Buy
7,577
+971
+15% +$45.8K 0.27% 101
2022
Q4
$306K Buy
+6,606
New +$286K 0.26% 105

Other funds holding BSX

Tilt Investment Management Holdings's BSX Position: Q4 2023 in Review

Tilt Investment Management Holdings reduced its Boston Scientific (BSX) stake by 21% in Q4 2023, selling an estimated $86.8K and leaving 5,950 shares worth $344K. The position accounts for 0.37% of the portfolio, ranked #74.

Tilt Investment Management Holdings first reported a position in BSX in Q4 2022 and has held it in 5 quarters since. The position peaked at $410K in Q2 2023. 1,149 funds tracked by Wall St. Rank hold BSX as of Q4 2023.

  • Tilt Investment Management Holdings held 5,950 shares of Boston Scientific worth $344K as of Q4 2023.
  • Tilt Investment Management Holdings sold 1,627 Boston Scientific shares in Q4 2023, an estimated $86.8K.
  • Boston Scientific made up 0.37% of Tilt Investment Management Holdings's portfolio in Q4 2023, its #74 holding.
  • Tilt Investment Management Holdings first reported a position in Boston Scientific in Q4 2022 and has held it in 5 quarters since.
  • Tilt Investment Management Holdings's Boston Scientific position peaked at $410K in Q2 2023.
  • 1,149 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2023.

Based on Tilt Investment Management Holdings's 13F filing for Q4 2023, filed 31 Jan 2024.